Tags:BioTechBusinessEngineeringIndustryLabManufacturingTechnologyTime
Biosyntia is an industrial biotech company developing bio-based manufacturing processes with core capabilities within strain engineering and fermentation. The company was founded in 2012 by Hans Genee, Andreas Lausten and serial entrepreneur, DTU Professor Morten Sommer. Today, 15 scientists and business developers operate from Biosyntia’s lab and offices in Copenhagen, Denmark. Biosyntia develops microbes and processes at an unprecedented speed and efficiency by employing its Biosynthetic Selections™ technology which dramatically reduce the risk, cost and time for developing fermentation processes.
Total raised: $11.71855M

Investors 1

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
07.07.2022-$11.71855M-finsmes.co...

Mentions in press and media 4

DateTitleDescriptionCategoryAuthorSource
07.07.2022Biosyntia ...Biosyntia, a Copenhagen, Denma...Denmark-finsmes.co...
23.12.2019MIT Techno...Since 1999, MIT Technology Rev...EcosystemBlanca Cap...startupsre...
14.03.2019Nutrition ...In the face of obesity, diabet...--agfunderne...
21.05.2015Biosyntia ...Biosyntia ApS, a Denmark-based...Denmark-finsmes.co...